[go: up one dir, main page]

EA201890597A1 - Содержащая цинеол водная композиция для назального применения - Google Patents

Содержащая цинеол водная композиция для назального применения

Info

Publication number
EA201890597A1
EA201890597A1 EA201890597A EA201890597A EA201890597A1 EA 201890597 A1 EA201890597 A1 EA 201890597A1 EA 201890597 A EA201890597 A EA 201890597A EA 201890597 A EA201890597 A EA 201890597A EA 201890597 A1 EA201890597 A1 EA 201890597A1
Authority
EA
Eurasian Patent Office
Prior art keywords
zineol
aqueous composition
basic application
pharmaceutical composition
basic
Prior art date
Application number
EA201890597A
Other languages
English (en)
Other versions
EA033828B1 (ru
Inventor
Маркус Ункауф
Михаэль Плох
Хосе Галан-Суза
Original Assignee
Мария Клементине Мартин Клостерфрау Фертрибсгезелльшафт Мбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мария Клементине Мартин Клостерфрау Фертрибсгезелльшафт Мбх filed Critical Мария Клементине Мартин Клостерфрау Фертрибсгезелльшафт Мбх
Publication of EA201890597A1 publication Critical patent/EA201890597A1/ru
Publication of EA033828B1 publication Critical patent/EA033828B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к содержащей цинеол фармацевтической композиции предпочтительно на водной основе для топического, в частности для назального и предпочтительно для интраназального применения, а также к ее применению и устройству для применения, вмещающему указанную фармацевтическую композицию.
EA201890597A 2015-09-01 2016-05-20 Содержащая цинеол водная композиция для назального применения EA033828B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102015011158 2015-09-01
DE102015011331 2015-09-03
DE102015115107.3A DE102015115107A1 (de) 2015-09-01 2015-09-08 Cineolhaltige wässrige Zusammensetzung für die nasale Applikation
PCT/EP2016/061430 WO2017036617A1 (de) 2015-09-01 2016-05-20 Cineolhaltige wässrige zusammensetzung für die nasale applikation

Publications (2)

Publication Number Publication Date
EA201890597A1 true EA201890597A1 (ru) 2018-07-31
EA033828B1 EA033828B1 (ru) 2019-11-29

Family

ID=56986023

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890597A EA033828B1 (ru) 2015-09-01 2016-05-20 Содержащая цинеол водная композиция для назального применения

Country Status (6)

Country Link
EP (1) EP3297603B1 (ru)
DE (2) DE102015115107A1 (ru)
EA (1) EA033828B1 (ru)
ES (1) ES2733903T3 (ru)
PL (1) PL3297603T3 (ru)
WO (1) WO2017036617A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2972897T3 (es) * 2017-08-10 2024-06-17 Elixir Ilac Arastirma Ve Gelistirme A S Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549421C2 (de) 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
US6482397B1 (en) * 1999-04-20 2002-11-19 Schering-Plough Healthcare Products, Inc. Coloring agent-containing sunless tanning compositions
DE20318634U1 (de) 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102013001151A1 (de) * 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE102014116903A1 (de) * 2014-08-18 2016-02-18 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation

Also Published As

Publication number Publication date
PL3297603T3 (pl) 2019-11-29
WO2017036617A1 (de) 2017-03-09
DE102015115107A1 (de) 2017-03-02
EP3297603B1 (de) 2019-05-08
EA033828B1 (ru) 2019-11-29
ES2733903T3 (es) 2019-12-03
DE202015104761U1 (de) 2016-09-02
EP3297603A1 (de) 2018-03-28

Similar Documents

Publication Publication Date Title
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
EA201991715A1 (ru) Композиции, содержащие антитело к pdl1
EA201790410A1 (ru) Содержащая цинеол композиция для назального применения
PL3297605T3 (pl) Kompozycje farmaceutyczne do stosowania miejscowego
EA201791299A1 (ru) Микроинкапсулированные композиции каннабиноидов
EA201591137A1 (ru) Ингибиторы mk2 и их применения
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112016006319A2 (pt) inibidores de irak e usos dos mesmos
BR112017005266A2 (pt) inibidores de mk2 e uso dos mesmos
EP3463360A4 (en) AQUEOUS COMPOSITION CONTAINING ATROPINE
EA201690613A1 (ru) Улучшенные составы на основе аденовирусов
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
EA201790785A1 (ru) Производные тетрагидроизохинолина
UA115373C2 (uk) Стабільний рідкий склад amg 416 (велкалсетиду)
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201791467A1 (ru) Водный офтальмологический раствор
EA201791174A1 (ru) Антимикотическое соединение
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
ITUB20152355A1 (it) Dispositivo di illuminazione, ad esempio per l'illuminazione di serre, e corrispondente procedimento di impiego
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201791716A1 (ru) Фармацевтический состав
EA201491300A1 (ru) Композиция для назального применения с улучшенной стабильностью
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU